MIS-C Comparative Effectiveness Study

NCT04898231 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Multisystem Inflammatory Syndrome-Children

Interventions

DRUG: Infliximab
DRUG: Anakinra
DRUG: Methylprednisolone

Sponsor

University of California, San Diego

Collaborators

[object Object]